RACHEL BEST: Open Payments
NPI 1710134499 · ALCOA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 12 payments from 8 companies in 2025. Trend: 2023 $101 · 2024 $225 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Eisai Inc. | 3 | $51 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: INGREZZA, Leqembi, INSPIRE, TRELEGY ELLIPTA, KISUNLA, AUSTEDO XR, Kerendia.
Industry payments across TN — which companies pay providers there.
